Friday, October 23, 2026

Technology Policy

3 articles

US and China Formalize Parallel AI Chip Supply Chains with Simultaneous Export Controls

US and China Formalize Parallel AI Chip Supply Chains with Simultaneous Export Controls

Washington banned Nvidia chip exports to China while Beijing approved select H200 chips and accelerated Huawei's 950PR processor development, creating two separate global AI infrastructure ecosystems. Multinational companies must now maintain dual development environments across CUDA and CANN platforms. Investment capital flows toward China-focused AI infrastructure firms that can navigate the bifurcated hardware landscape.

LM Salvado•
US Export Controls Block Malaysian Cloud Provider's Nvidia Blackwell Deal with ByteDance

US Export Controls Block Malaysian Cloud Provider's Nvidia Blackwell Deal with ByteDance

American semiconductor export restrictions threaten to block Aolani Cloud's deployment of Nvidia Blackwell GPUs in Malaysia through its partnership with ByteDance. The restrictions reflect escalating US-China technology competition reshaping Asian cloud infrastructure markets as providers seek neutral ground outside both powers.

LM Salvado•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com